Estrogen exposure is a major risk factor for breast cancer. Increased estrogen responsiveness of breast epithelium may enhance this effect. Surgical or medical castration and antiestrogenic treatment with tamoxifen are common endocrine treatments for premenopausal women with breast cancer.However, tamoxifen therapy induces high levels of plasma estradiol, with unknown long-term effects. In this study, we investigated the effect of combining the luteinizing hormone-releasing hormone agonist with tamoxifen and measuring estradiol level . method : Are taking random samples of breast cancer patients under treatment of patients attending the Institute of Atomic Radiation in Baghdad , and specifically who use Tamoxifen ( 20 mg/day) . 100 samples and 30 sample as a control there age ( 20 -80). Approximately 3ml of blood are collected from each women using standard procedures. And then measuring the level of estradiol E2 hormone ,Measurement of the liver enzymes ( GOT,GPT,ALP,LDH and GGT ) and billirubin for study the liver health results : combined treatment with tamoxifen and
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.